Strange Reviewing

Strange Reviewing In the July 11, 1988, issue of The Scientist, Rex Dalton discusses whether reviewers should sign their critiques. I have had several disappointing experiences, and suspect that the unknown reviewers of the Anglo-American medical journals either do not know the English language or are all licted with “sleeping sickness” or are gifted with Mach-2 speed. Four examples illustrate this: 1. A paper dealing with congenital disorders associated with sensorineural deafness

Written byArnaldo Cantani
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the July 11, 1988, issue of The Scientist, Rex Dalton discusses whether reviewers should sign their critiques. I have had several disappointing experiences, and suspect that the unknown reviewers of the Anglo-American medical journals either do not know the English language or are all licted with “sleeping sickness” or are gifted with Mach-2 speed. Four examples illustrate this:

1. A paper dealing with congenital disorders associated with sensorineural deafness was sent to a leading otorhinolaryngological journal. The referees blamed the authors because they failed to discuss the Treacher-Collins syndrome, which of course falls in a different medical category.

2. In another journal, authors reporting on a rare syndrome stated that they were aware of only one pediatric case of that syndrome. A letter was then sent to the journal illustrating 17 pediatric cases. But the letter was refused by a reviewer because the topic of respiratory failure (which killed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies